These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 557207)

  • 1. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects of a new non-phenylethylamine anorexigenic agent: mazindol.
    Zambotti F; Carruba MO; Barzaghi F; Vicentini L; Groppetti A; Mantegazza P
    Eur J Pharmacol; 1976 Apr; 36(2):405-12. PubMed ID: 945167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of selected CNS depressants with d-amphetamine or mazindol on food intake and motor activity of rats.
    Iorio LC; Ryan EA; Gogerty JH
    Eur J Pharmacol; 1976 Mar; 36(1):89-94. PubMed ID: 1261608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol).
    Gogerty JH; Penberthy C; Iorio LC; Trapold JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):285-307. PubMed ID: 1171662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo (2, 1-a) isoindole (mazindol, SaH 42-548) on the metabolism of brain norepinephrine.
    Engstrom RG; Kelly LA; Gogerty JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):308-21. PubMed ID: 1156036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
    [No Abstract]   [Full Text] [Related]  

  • 8. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL; Zarrindast MR
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies with several analogs of mazindol: correlation between effects on dopamine uptake and various in vivo responses.
    Heikkila RE; Babington RG; Houlihan WJ
    Eur J Pharmacol; 1981 May; 71(2-3):277-86. PubMed ID: 7250190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cyclo(His-Pro) act like amphetamine?
    Mizuma H; Shimizu I; Hilton C; Prasad C
    Life Sci; 1994; 54(21):1625-33. PubMed ID: 8196482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)Deprenyl (selegiline) is devoid of amphetamine-like behavioural effects in rats.
    Tímár J; Knoll B; Knoll J
    Acta Physiol Hung; 1992; 79(2):131-7. PubMed ID: 1363925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological action of mazindol on behaviors and metabolism].
    Nagai K; Mori T; Ookura M; Tsujimoto H; Nakagawa H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):133-45. PubMed ID: 6745804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aryl-2,3-dihydro-5H-imidazo[2,1-a]isoindol-5-ols. A novel class of anorectic agents.
    Aeberli P; Eden P; Gogerty JH; Houlihan WJ; Penberthy C
    J Med Chem; 1975 Feb; 18(2):177-82. PubMed ID: 804553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further analysis of the resistance of the diabetic rat to d-amphetamine.
    Marshall JF
    Pharmacol Biochem Behav; 1978 Mar; 8(3):281-6. PubMed ID: 565933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol.
    Leibowitz SF; Rossakis C
    Eur J Pharmacol; 1978 Dec; 53(1):69-81. PubMed ID: 738361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mazindol, d-amphetamine and diethylpropion on purine nucleotide binding to brown adipose tissue.
    Lupien JR; Bray GA
    Pharmacol Biochem Behav; 1986 Oct; 25(4):733-8. PubMed ID: 3786335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.